StockData
Apollomics Inc. logo

Apollomics Inc. (APLM) stock

APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026Score 0/30
$17.68+0.38 (+2.20%)

Close on Nov 13, 2026Market cap $38.83MP/E –Yield –

Earnings

Apollomics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Apollomics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2023ended Jun 30, 2023Sep 28, 2023during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Apollomics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Apollomics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Apollomics filed with the SEC as exhibits to Form 8-K or 6-K

  1. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    6-K
  2. Apollomics Announces $10 Million Private Placement Transaction
    6-K
  3. Apollomics Regains Full Compliance with Nasdaq Listing Requirements
    6-K
  4. Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value
    6-K
  5. Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress
    6-K
  6. Apollomics Inc. Announces $2.0 Million Bridge Financing
    6-K
  7. INDEX TO UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
    6-K
  8. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    6-K
  9. Apollomics Reports First Half 2025 Financial Results
    6-K
  10. FOSTER CITY, CA, UNITED STATES, November 19, 2025
    6-K
  11. its Board of Directors and Composition of Committees
    6-K
  12. Listing on The Nasdaq Stock
    6-K
  13. Your publication date and time will appear here. | Source: Apollomics Inc.
    6-K
  14. Apollomics Announces Receipt of Nasdaq
    6-K
  15. Apollomics Announces Completion of Filing of Appeal of Nasdaq Delisting Order
    6-K

See a number that looks wrong?